AAAAAA

   
Results: 1-12 |
Results: 12
ADMA (asymmetric dimethylarginine): an atherosclerotic disease mediating agent in patients with renal disease?
Authors: Kielstein, JT Frolich, JC Haller, H Fliser, D
Citation: Jt. Kielstein et al., ADMA (asymmetric dimethylarginine): an atherosclerotic disease mediating agent in patients with renal disease?, NEPH DIAL T, 16(9), 2001, pp. 1742-1745
Right-sided chest pain at the onset of haemodialysis
Authors: Kielstein, JT Abou-Rebyeh, F Hafer, C Haller, H Fliser, D
Citation: Jt. Kielstein et al., Right-sided chest pain at the onset of haemodialysis, NEPH DIAL T, 16(7), 2001, pp. 1493-1495
Serum cystatin C concentration as a marker of renal dysfunction in the elderly - Reply
Authors: Ritz, E Fliser, D
Citation: E. Ritz et D. Fliser, Serum cystatin C concentration as a marker of renal dysfunction in the elderly - Reply, AM J KIDNEY, 37(2), 2001, pp. 450-451
Serum cystatin C concentration as a marker of renal dysfunction in the elderly
Authors: Fliser, D Ritz, E
Citation: D. Fliser et E. Ritz, Serum cystatin C concentration as a marker of renal dysfunction in the elderly, AM J KIDNEY, 37(1), 2001, pp. 79-83
Fulminant course of leptospirosis complicated by multiple organ failure
Authors: Kirchner, GI Krug, N Bleck, JS Fliser, D Manns, MP Wagner, S
Citation: Gi. Kirchner et al., Fulminant course of leptospirosis complicated by multiple organ failure, Z GASTROENT, 39(8), 2001, pp. 587
Opposing effects of angiotensin II on muscle and renal blood flow under euglycemic conditions
Authors: Fliser, D Dikow, R Demukaj, S Ritz, E
Citation: D. Fliser et al., Opposing effects of angiotensin II on muscle and renal blood flow under euglycemic conditions, J AM S NEPH, 11(11), 2000, pp. 2001-2006
Nephropathy in non-insulin-dependent diabetes
Authors: Fliser, D Haller, H
Citation: D. Fliser et H. Haller, Nephropathy in non-insulin-dependent diabetes, INTERNIST, 41(12), 2000, pp. 1363
Disturbances in the calcium and phosphate serum level
Authors: Fliser, D Ritz, E
Citation: D. Fliser et E. Ritz, Disturbances in the calcium and phosphate serum level, UROLOGE, 38(3), 1999, pp. 285-295
How can we improve prognosis in diabetic patients with end-stage renal disease?
Authors: Ritz, E Koch, M Fliser, D Schwenger, V
Citation: E. Ritz et al., How can we improve prognosis in diabetic patients with end-stage renal disease?, DIABET CARE, 22, 1999, pp. B80-B83
Coadministration of albumin and furosemide in patients with the nephrotic syndrome
Authors: Fliser, D Zurbruggen, I Mutschler, E Bischoff, I Nussberger, J Franek, E Ritz, E
Citation: D. Fliser et al., Coadministration of albumin and furosemide in patients with the nephrotic syndrome, KIDNEY INT, 55(2), 1999, pp. 629-634
Renal handling of drugs in the healthy elderly - Creatinine clearance underestimates renal function and pharmacokinetics remain virtually unchanged
Authors: Fliser, D Bischoff, I Hanses, A Block, S Joest, M Ritz, E Mutschler, E
Citation: D. Fliser et al., Renal handling of drugs in the healthy elderly - Creatinine clearance underestimates renal function and pharmacokinetics remain virtually unchanged, EUR J CL PH, 55(3), 1999, pp. 205-211
Endstage renal failure in diabetes type II - a silent epidemic
Authors: Ritz, E Miltenberger-Miltenyi, G Rychlik, I Fliser, D
Citation: E. Ritz et al., Endstage renal failure in diabetes type II - a silent epidemic, NEPHROLOGY, 4(5-6), 1998, pp. 299-302
Risultati: 1-12 |